» Articles » PMID: 7929824

Sex-specific Action of Insulin to Acutely Increase the Metabolic Clearance Rate of Dehydroepiandrosterone in Humans

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1994 Oct 1
PMID 7929824
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

To test the hypothesis that insulin acutely enhances the metabolic clearance rate (MCR) of dehydroepiandrosterone in humans, the effect of a short-term insulin infusion on the MCR of dehydroepiandrosterone was assessed in 10 men and 7 women. After an overnight fast, dehydroepiandrosterone was infused at 3.47 mumol/h for 6.5 h. At 240 min, a hyperinsulinemic-euglycemic clamp was begun by infusing insulin at 21.5 pmol/kg per min for 2.5 h. MCR of dehydroepiandrosterone was calculated at baseline (210-240 min) and during the insulin infusion (360-390 min). A control study was conducted at least 1 wk later, in which 0.45% saline was substituted for the hyperinsulinemic-euglycemic clamp. During the insulin clamp study, serum insulin rose from 34 +/- 2 to 1084 +/- 136 pmol/liter (P = 0.0001) in men and from 40 +/- 5 to 1357 +/- 175 pmol/liter (P = 0.0003) in women, while serum glucose remained constant in both groups. MCR of dehydroepiandrosterone rose in men during the insulin infusion from 2443 +/- 409 to 3599 +/- 500 liters/24 h (P = 0.003), but did not change during the control saline infusion. In contrast, MCR of dehydroepiandrosterone in women did not change in the insulin clamp study during insulin infusion (2526 +/- 495 liters/24 h at baseline vs. 2442 +/- 491 liters/24 h during insulin infusion; P = 0.78). These findings suggest that insulin acutely increases the MCR of dehydroepiandrosterone in men but not in women.

Citing Articles

Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?.

Jarecki P, Herman W, Pawliczak E, Lacka K Diabetes Metab Syndr Obes. 2019; 12:2181-2191.

PMID: 31695461 PMC: 6814954. DOI: 10.2147/DMSO.S218545.


Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Diamanti-Kandarakis E, Dunaif A Endocr Rev. 2012; 33(6):981-1030.

PMID: 23065822 PMC: 5393155. DOI: 10.1210/er.2011-1034.


The biological actions of dehydroepiandrosterone involves multiple receptors.

Webb S, Geoghegan T, Prough R, Miller K Drug Metab Rev. 2006; 38(1-2):89-116.

PMID: 16684650 PMC: 2423429. DOI: 10.1080/03602530600569877.


Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome.

Carmina E, Lobo R J Endocrinol Invest. 1998; 21(9):580-8.

PMID: 9856412 DOI: 10.1007/BF03350783.


The short-term effect of dietary pectin on plasma levels and renal excretion of dehydroepiandrosterone sulfate.

Remer T, Pietrzik K, Manz F Z Ernahrungswiss. 1996; 35(1):32-8.

PMID: 8776832 DOI: 10.1007/BF01612025.

References
1.
ISHIHARA F, Hiramatsu K, Shigematsu S, Aizawa T, Niwa A, Takasu N . Role of adrenal androgens in the development of arteriosclerosis as judged by pulse wave velocity and calcification of the aorta. Cardiology. 1992; 80(5-6):332-8. DOI: 10.1159/000175022. View

2.
Pashko L, Schwartz A . Antihyperglycemic effect of dehydroepiandrosterone analogue 16 alpha-fluoro-5-androsten-17-one in diabetic mice. Diabetes. 1993; 42(8):1105-8. DOI: 10.2337/diab.42.8.1105. View

3.
Nieschlag E, Loriaux D, Ruder H, ZUCKER I, KIRSCHNER M, LIPSETT M . The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Endocrinol. 1973; 57(1):123-34. DOI: 10.1677/joe.0.0570123. View

4.
Nestler J, McClanahan M, CLORE J, BLACKARD W . Insulin inhibits adrenal 17,20-lyase activity in man. J Clin Endocrinol Metab. 1992; 74(2):362-7. DOI: 10.1210/jcem.74.2.1730815. View

5.
Haffner S, Mykkanen L, Valdez R, Katz M . Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metab. 1993; 77(6):1610-5. DOI: 10.1210/jcem.77.6.8263149. View